Hanmi Science (008930) - Total Liabilities

Latest as of March 2026: ₩494.84 Billion KRW ≈ $335.34 Million USD

Based on the latest financial reports, Hanmi Science (008930) has total liabilities worth ₩494.84 Billion KRW (≈ $335.34 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 008930 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Hanmi Science - Total Liabilities Trend (2000–2025)

This chart illustrates how Hanmi Science's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Hanmi Science asset portfolio.

Hanmi Science Competitors by Total Liabilities

The table below lists competitors of Hanmi Science ranked by their total liabilities.

Company Country Total Liabilities
Gujarat Gas Limited
NSE:GUJGASLTD
India Rs86.88 Billion
SCHOTT Pharma AG & Co. KGaA
XETRA:1SXP
Germany €650.00 Million
Bilfinger SE
XETRA:GBF
Germany €2.31 Billion
Coface SA
PA:COFA
France €6.30 Billion
Eclat Textile Co Ltd
TW:1476
Taiwan NT$5.60 Billion
Shanghai Beite Technology Co
SHG:603009
China CN¥1.87 Billion
CECEP Solar Energy Co Ltd
SHE:000591
China CN¥28.42 Billion
DO & CO Aktiengesellschaft
VI:DOC
Austria €737.35 Million

Liability Composition Analysis (2000–2025)

This chart breaks down Hanmi Science's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Hanmi Science net asset quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.87 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.49 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.33 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Hanmi Science's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Hanmi Science (2000–2025)

The table below shows the annual total liabilities of Hanmi Science from 2000 to 2025.

Year Total Liabilities Change
2025-12-31 ₩529.85 Billion
≈ $359.07 Million
+3.82%
2024-12-31 ₩510.38 Billion
≈ $345.87 Million
+16.34%
2023-12-31 ₩438.70 Billion
≈ $297.30 Million
+13.96%
2022-12-31 ₩384.94 Billion
≈ $260.87 Million
+48.28%
2021-12-31 ₩259.60 Billion
≈ $175.93 Million
-1.85%
2020-12-31 ₩264.49 Billion
≈ $179.24 Million
-0.25%
2019-12-31 ₩265.15 Billion
≈ $179.69 Million
+0.64%
2018-12-31 ₩263.45 Billion
≈ $178.54 Million
-3.72%
2017-12-31 ₩273.63 Billion
≈ $185.44 Million
-14.94%
2016-12-31 ₩321.68 Billion
≈ $218.00 Million
-7.50%
2015-12-31 ₩347.77 Billion
≈ $235.68 Million
+6.98%
2014-12-31 ₩325.08 Billion
≈ $220.30 Million
+90.38%
2013-12-31 ₩170.76 Billion
≈ $115.72 Million
+86.62%
2012-12-31 ₩91.50 Billion
≈ $62.01 Million
+169.83%
2011-12-31 ₩33.91 Billion
≈ $22.98 Million
-92.02%
2010-12-31 ₩424.95 Billion
≈ $287.98 Million
-5.69%
2009-12-31 ₩450.57 Billion
≈ $305.34 Million
+1.15%
2008-12-31 ₩445.43 Billion
≈ $301.86 Million
+31.25%
2007-12-31 ₩339.39 Billion
≈ $230.00 Million
+44.80%
2006-12-31 ₩234.39 Billion
≈ $158.84 Million
+23.83%
2005-12-31 ₩189.29 Billion
≈ $128.28 Million
+3.40%
2004-12-31 ₩183.07 Billion
≈ $124.06 Million
+6.31%
2003-12-31 ₩172.20 Billion
≈ $116.70 Million
+8.25%
2002-12-31 ₩159.07 Billion
≈ $107.80 Million
-3.08%
2001-12-31 ₩164.13 Billion
≈ $111.23 Million
+5.05%
2000-12-31 ₩156.24 Billion
≈ $105.88 Million
--

About Hanmi Science

KO:008930 Korea Medical Distribution
Market Cap
$2.39 Billion
₩3.53 Trillion KRW
Market Cap Rank
#5585 Global
#128 in Korea
Share Price
₩52100.00
Change (1 day)
+2.76%
52-Week Range
₩26100.00 - ₩57700.00
All Time High
₩138933.39
About

Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult's bowel preparation and cold medicines, and cephalosporin antibiotics. The company also offers general foods, health functional foods, soy milk, and medical equipment. In addition… Read more